Erika Martinelli

6PUBLICATIONS
35CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 12, 2024
Upfront Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan Plus Bevacizumab With or Without Atezolizumab for Patients With Metastatic Colorectal Cancer: Updated and Overall Survival Results of the ATEZOTRIBE Study.

Carlotta Antoniotti, Daniele Rossini, Filippo Pietrantonio

|Apr 11, 2023
Antitumor Efficacy of Dual Blockade with Encorafenib + Cetuximab in Combination with Chemotherapy in Human BRAFV600E-Mutant Colorectal Cancer.

Stefania Napolitano, Melanie Woods, Hey Min Lee

|Mar 07, 2023
Cetuximab as third-line rechallenge plus either irinotecan or avelumab is an effective treatment in metastatic colorectal cancer patients with baseline plasma RAS/BRAF wild-type circulating tumor DNA: Individual patient data pooled analysis of CRICKET and CAVE trials.

G Martini, D Ciardiello, V Famiglietti

|Feb 11, 2021
Dual inhibition of TGFβ and AXL as a novel therapy for human colorectal adenocarcinoma with mesenchymal phenotype.

Davide Ciardiello, Bernadette Blauensteiner, Nunzia Matrone

|Apr 03, 2020
Feasibility of next-generation sequencing in clinical practice: results of a pilot study in the Department of Precision Medicine at the University of Campania 'Luigi Vanvitelli'.

Vincenzo De Falco, Luca Poliero, Pietro Paolo Vitello

|Mar 30, 2020
Towards the era of precision medicine in metastatic colorectal cancer.

Stefania Napolitano, Teresa Troiani, Erika Martinelli

Pageof 1

Frequent Collaborators

2 joint publications

Giulia Martini

2 joint publications

Davide Ciardiello

2 joint publications

Filippo Pietrantonio

2 joint publications

Vincenzo De Falco